Retractable Technologies (NYSE:RVP) and TELA Bio (NASDAQ:TELA) Head to Head Review

Retractable Technologies (NYSE:RVPGet Free Report) and TELA Bio (NASDAQ:TELAGet Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

Profitability

This table compares Retractable Technologies and TELA Bio’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Retractable Technologies -41.11% -17.15% -9.33%
TELA Bio -60.49% -556.18% -63.13%

Analyst Ratings

This is a summary of recent ratings and recommmendations for Retractable Technologies and TELA Bio, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies 0 0 0 0 0.00
TELA Bio 0 1 3 0 2.75

TELA Bio has a consensus price target of $7.25, indicating a potential upside of 655.76%. Given TELA Bio’s stronger consensus rating and higher probable upside, analysts clearly believe TELA Bio is more favorable than Retractable Technologies.

Risk & Volatility

Retractable Technologies has a beta of 2.28, meaning that its stock price is 128% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.

Institutional & Insider Ownership

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 57.1% of Retractable Technologies shares are held by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Retractable Technologies and TELA Bio”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Retractable Technologies $33.05 million 0.66 -$7.01 million ($0.41) -1.77
TELA Bio $69.30 million 0.55 -$46.66 million ($1.39) -0.69

Retractable Technologies has higher earnings, but lower revenue than TELA Bio. Retractable Technologies is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Summary

Retractable Technologies beats TELA Bio on 8 of the 14 factors compared between the two stocks.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

About TELA Bio

(Get Free Report)

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.